Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine

Eur J Pharmacol. 1992 Sep 1;228(2-3):171-4. doi: 10.1016/0926-6917(92)90027-a.

Abstract

The effects of 1-piperonylpiperazine and N,alpha-dimethylpiperonylamine, which are weak inhibitors for [3H]5-hydroxytryptamine (5-HT) uptake, on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity were examined. The reductions of serotonergic parameters in the rat cerebral cortex produced by multiple administration of MDMA (10 mg/kg) were attenuated significantly by coadministration of 6-nitroquipazine (10 mg/kg), paroxetine (10 mg/kg) or 1-piperonylpiperazine (20 mg/kg), but not by N,alpha-dimethylpiperonylamine (20 mg/kg). The present data suggest that 1-piperonylpiperazine might inhibit the MDMA-induced neurotoxicity by effect(s) other than 5-HT uptake inhibition.

MeSH terms

  • 3,4-Methylenedioxyamphetamine / analogs & derivatives*
  • 3,4-Methylenedioxyamphetamine / antagonists & inhibitors
  • 3,4-Methylenedioxyamphetamine / toxicity
  • Animals
  • Brain / drug effects*
  • Brain / metabolism
  • Hydroxyindoleacetic Acid / metabolism
  • Injections, Intraperitoneal
  • Male
  • N-Methyl-3,4-methylenedioxyamphetamine
  • Piperazines / pharmacology*
  • Quipazine / analogs & derivatives
  • Quipazine / pharmacology
  • Rats
  • Rats, Wistar
  • Selective Serotonin Reuptake Inhibitors / pharmacology*
  • Serotonin / metabolism
  • Serotonin Antagonists / pharmacology

Substances

  • Piperazines
  • Serotonin Antagonists
  • Serotonin Uptake Inhibitors
  • 1-piperonylpiperazine
  • Serotonin
  • 3,4-Methylenedioxyamphetamine
  • Quipazine
  • Hydroxyindoleacetic Acid
  • 6-nitroquipazine
  • N-Methyl-3,4-methylenedioxyamphetamine